Inventor
Viktor S. Goldmakher
Inventor
Newton, MA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides19%
C12NMicroorganisms or enzymes15%
C07HSugars11%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C07DHeterocyclic compounds2%
PatentTitleYear
10,752,683Folate receptor 1 antibodies and immunoconjugates and uses thereof202010,301,385Folate receptor 1 antibodies and immunoconjugates and uses thereof20199,670,280'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,670,278'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,670,279'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,657,100'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,598,490'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20179,133,275'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20158,840,898'Immunoconjugates targeting syndecan-1 expressing cells and use thereof'20148,557,966'Folate receptor 1 antibodies and immunoconjugates and uses thereof'20138,388,960'Elimination of heterogeneous or mixed cell population in tumors'20138,137,669'Elimination of heterogeneous or mixed cell population in tumors'20127,449,450'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products'20087,202,346'Antibodies to non-shed Muc1 and Muc16, and uses thereof'20076,902,885'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products'20056,605,426'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products'20036,218,511'Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use'20015,846,545'Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs'19985,585,499'Cyclopropylbenzindole-containing cytotoxic drugs'19965,475,092'Cell binding agent conjugates of analogues and derivatives of CC-1065'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2020Patents assigned to IMMUNOGEN INC (17)· patent assignee history
1995–2020Based in Newton, MA, US· patent location history
1998Based in Newton Center, MA, US· patent location history
2001–2005Patents assigned to APOPTOSIS TECHNOLOGY INC (3)· patent assignee history
2012–2014Patents assigned to GOLDMAKHER VIKTOR S (4)· patent assignee history
2012–2013Patents assigned to CHARI RAVI V J (2)· patent assignee history
2012–2013Patents assigned to ERICKSON HANS K (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 17 | 1995–2020 |
| GOLDMAKHER VIKTOR Sself | 4 | 2012–2014 |
| APOPTOSIS TECHNOLOGY INC | 3 | 2001–2005 |
| CHARI RAVI V J | 2 | 2012–2013 |
| ERICKSON HANS K | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newton, Massachusetts, US | 19 | 1995–2020 |
| Newton Center, Massachusetts, US | 1 | 1998 |